Looking for Sentiment Analysis? Discover the most popular stocks on Reddit by using our Sentiment Tracker
Market Cap 27.58M P/E - EPS this Y 43.90% Ern Qtrly Grth -
Income -10.65M Forward P/E -1.80 EPS next Y -37.50% 50D Avg Chg 22.00%
Sales - PEG - EPS past 5Y - 200D Avg Chg -27.00%
Dividend N/A Price/Book N/A EPS next 5Y - 52W High Chg -72.00%
Recommedations 2.00 Quick Ratio 0.02 Shares Outstanding 28.90M 52W Low Chg 99.00%
Insider Own 48.62% ROA -81.20% Shares Float 18.83M Beta -0.06
Inst Own 4.41% ROE - Shares Shorted/Prior 52.57K/192.20K Price 0.95
Gross Margin - Profit Margin - Avg. Volume 58,762 Target Price 1.50
Oper. Margin - Earnings Date Jul 12 Volume 16,808 Change 6.03%
About Nemaura Medical Inc.

Nemaura Medical Inc., a medical technology company, manufactures continuous glucose monitoring system in the United States. It offers sugarBEAT, a non-invasive continuous glucose monitoring device for use by persons with Type I and Type II diabetes, as well as screen pre-diabetic patients. The company also offers proBEAT, a wellness guidance notes, that provide prompts and educate users on factors affecting blood sugar profiles, as well as conducts diabetes prevention and reversal programs. Nemaura Medical Inc. was founded in 2009 and is based in New York, New York.

Nemaura Medical Inc. News
01/22/24 Maxim Group LLC to Host the 2024 Healthcare IT Virtual Conference on Wednesday, January 24th & Thursday, January 25th at 9:00 A.M. ET
01/03/24 Important Update on Listing Status and Strategic Direction
12/13/23 Nemaura Medical Inc. Receives Positive Nasdaq Listing Decision
11/21/23 Nemaura Medical Inc. Secures $10 Million Non-Dilutive Credit Facility to Fuel Strategic Growth
11/17/23 Nemaura (NMRD) to Expand in UK With Metabolic Health Program
11/16/23 Nemaura Medical First Half 2024 Earnings: US$0.13 loss per share (vs US$0.33 loss in 1H 2023)
11/14/23 Sidoti Events, LLC’s Virtual November Micro-Cap Conference
11/14/23 Nemaura Launches Direct to Consumer Offering of Metabolic Health Program in Combination with GLP-1 Weight Loss Drugs
11/13/23 Nemaura Medical Reports Fiscal Second Quarter 2024 Results and Provides Business Update
09/26/23 Nemaura Medical Announces Appointment of Mr Nikolai Rozanov as Strategic Adviser in Artificial Intelligence, to Assist in Development of its AI Health Coach, and Strengthen Outcomes in its CGM Based Metabolic and Type 2 Diabetes Programs.
09/22/23 Maxim Group LLC to Host the Virtual Tech Conference Series: Emerging Growth in A.I., on Tuesday, September 26th & Wednesday, September 27th at 8:00 A.M. ET.
09/18/23 Nemaura Medical to Present at the Maxim Group Emerging Growth in A.I. Conference
09/14/23 Nemaura Medical Provides Update on Nasdaq Compliance Status and Process
09/13/23 Nemaura Medical Announces Interim Results from its Collaboration with the UK’s National Health Service on its Metabolic Health & Weight Loss Program
09/12/23 Nemaura Medical Announces Participation at HLTH 2023, Las Vegas
08/23/23 Nemaura Medical, Inc. (NMRD) Upgraded to Buy: What Does It Mean for the Stock?
08/17/23 Nemaura Medical Announces SFDA Approval of sugarBEAT®
08/14/23 Nemaura Medical Reports Fiscal First Quarter 2024 Results and Provides Business Update
08/11/23 Nemaura Medical Secures $6.5m in Non-Dilutive Funding
07/14/23 Nemaura Medical Reports Financial Results and Provides Business Update for the Fiscal Year Ended March 31, 2023
NMRD Chatroom

User Image GoGreen21 Posted - 3 weeks ago

$NMRD Doubled my holdings on the dip today. Should have news any day now.

User Image WhiskyBusiness Posted - 1 month ago

$NMRD Does anyone know if form 25-NSE posted on 3/21 pertains specifically to Nasdaq Cap delisting from January or is this notice of not being traded on any exchange period ?

User Image WhiskyBusiness Posted - 2 months ago

$NMRD should be getting partnership news with Fiscal year March 31st approaching and authorized shares now approved . Let’s hope this milestone achieved per Faz’s previous interview comments

User Image surferbja Posted - 2 months ago

$NMRD The Next Level in Health Tracking https://miboko.com/sensors/ Most health trackers measure what you’re doing – like how many steps you take or how many minutes you’re active each day. Our wearable sensor measures what’s actually going on inside your body. Specifically, it tracks your metabolism, showing you how your body is responding to sugar. Because that’s actually the main influencer of everything from your appetite and weight to how well you sleep, how much energy you have, and even your mood. And longer-term it’s a big factor in chronic diseases like diabetes, heart disease, and dementia.

User Image surferbja Posted - 2 months ago

$NMRD Analyst Edward Woo, Ascendiant Buy 12/15/23 $3.50 In addition to the medical applications, we have developed Miboko, (www.Miboko.com), a digital healthcare program with the glucose sensor at its heart. We believe Miboko addresses a significant mass market opportunity that we believe could benefit roughly a third to half of the population by using a non-invasive glucose sensor to measure and monitor a user’s metabolic health score, which is based on glucose tolerance or insulin resistance. Those with prediabetes or obesity concerns, or even those looking to maintain better health through more careful glucose control, may benefit from such a metabolic health program. How one’s body metabolizes sugar is the main influencer of one’s appetite, weight, sleep quality, energy, and mood levels and even plays a critical factor in chronic diseases (beyond just diabetes), such as heart disease and dementia.

User Image surferbja Posted - 2 months ago

$NMRD Nemaura has combined our in-house diagnostic platform technology and artificial intelligence (AI) development capabilities with digital healthcare platforms through partnerships. We are positioning ourselves to become a significant player in the digital healthcare revolution through our technology offerings that will combine AI, devices, and digital platforms.

User Image surferbja Posted - 2 months ago

$NMRD Nemaura Medical evolved from a microsystem-based drug delivery platform that was developed in 2011. Since then, we have expanded the platform to allow the monitoring of multiple chemicals in the blood, without using needles. Replacing traditional invasive methods of diagnosis and healthcare observation procedures, our BEAT® technology will allow for remote continuous monitoring of chronic diseases and health conditions. One of the great advantages of our product, apart from eliminating the need to draw blood samples or inserting needles or sensors into the skin, is that a person can wear the device on whatever day they choose and for however long they choose. This is a unique feature of our device that has vast potential to change the way we manage chronic disease conditions.

User Image AnotherPOS Posted - 3 months ago

$NMRD vote no to everything. Shouldn't get more money for running shareholder value to zero!

User Image cctranscripts Posted - 3 months ago

Nemaura Medical: [X] No Fee Required https://www.conferencecalltranscripts.org/summary/?id=12873503 $NMRD

User Image cctranscripts Posted - 3 months ago

Nemaura Medical, Inc. releases salary data. CEO sees compensation rise 141% https://www.conferencecalltranscripts.org/summary/?id=12873473 $NMRD

User Image risenhoover Posted - 3 months ago

$NMRD / Nemaura Medical files form DEF 14A https://fintel.io/doc/sec-nemaura-medical-inc-1602078-def-14a-2024-january-17-19739-1075?utm_source=stocktwits.com&utm_medium=referral&utm_campaign=filing

User Image tickeron Posted - 3 months ago

What do you think of this? $NMRD RSI Indicator left the oversold zone. View odds of downtrend. https://srnk.us/go/4965520

User Image MarketBeatInsiderTrades Posted - 3 months ago

Nemaura Medical COO Arash Ghadar-Ghadr Buys $14,000.00 in $NMRD www.marketbeat.com/stocks/NASDAQ/NMRD/insider-trades/

User Image cctranscripts Posted - 3 months ago

Nemaura Medical, Inc.'s Chief Operating Officer just declared ownership of no shares of Nemaura https://www.conferencecalltranscripts.org/summary/?id=12855024 $NMRD

User Image risenhoover Posted - 3 months ago

Insider Arash Ghadar-Ghadr reports buying 100,000 shares of $NMRD for a total cost of $14,000.00 https://fintel.io/n/us/nmrd/ghadar-ghadr-arash?utm_source=stocktwits.com&utm_medium=referral&utm_campaign=insider

User Image VeronicaJRhoads Posted - 3 months ago

$NMRD $HALL Analyst price target for today- top-gains-stock-chat-today.blogspot.com/2024/01/top-gains-stock-chat-today.html

User Image tickeron Posted - 3 months ago

What do you think of this? $NMRD price may climb as it broke lower Bollinger Band. View odds of downtrend. https://srnk.us/go/4961114

User Image dbr_island Posted - 3 months ago

$HRYU is soon to squeeze folks…🍋💦💦💦 $AGL $IVP $NMRD $BETSF watching HRYU about to break $1 and possibly halt up due to this..👇

User Image Gogobabyboy Posted - 3 months ago

$BETSF $NMRD $FFIE $HRYU $IVP

User Image DaBullRunner Posted - 3 months ago

$HRYU and here’s why👇 $BETSF $MPW $NMRD $IVP making it up at HRYU

User Image nUme22 Posted - 3 months ago

$NMRD would drop below .05 .. seesh.. do they have any potential on anything ? This seems like a last ditch attempt to milk more money from retail

User Image AlertsAndNews Posted - 3 months ago

Updated gappers in after hours $DRMA $IVP $ZCAR $LGHL $NMRD Cant wait for tomorrow. Lets finish the week strong tomorrow! ✅

User Image dbr_island Posted - 3 months ago

$SING could soon squeeze like $DRMA $IVP $NMRD 👇

User Image AggressiveHulk Posted - 3 months ago

$IVP $1.76 EMA 200 target. $DRMA $NMRD $DTSS

User Image nUme22 Posted - 3 months ago

$NMRD reason they went to OTC is due to the fact that they could not get any tutes investing in them and then also could not get approvals to RS.. OTC means slow death..

User Image tickeron Posted - 3 months ago

Wow this is a big change! $NMRD entered a Downtrend because Momentum Indicator dropped below the 0 level. View odds of downtrend. https://srnk.us/go/4960020

User Image Robere Posted - 3 months ago

$NMRD I pulled out, bit of a loss I was hoping for their suspension to extend longer than January 5, in anycase Good luck all.

User Image Robere Posted - 3 months ago

$NMRD Subsequently, on January 3, 2024, the Company received written notice from Nasdaq indicating that the Nasdaq Hearings Panel has determined to delist the Company’s shares from Nasdaq. Trading in the Company’s shares on Nasdaq will be suspended effective January 5, 2023. Although the Company may request a review of the Nasdaq Hearings Panel’s decision, the Company does not intend to request such a review.

User Image Robere Posted - 3 months ago

$NMRD waiting till next week, before pulling out Have a great day everyone

User Image Last10K Posted - 3 months ago

$NMRD just filed with the SEC a Listing Status and a Financial Exhibit https://last10k.com/sec-filings/NMRD/0001079973-24-000008.htm?utm_source=stocktwits&utm_medium=forum&utm_campaign=8K&utm_term=NMRD

Analyst Ratings
HC Wainwright & Co. Buy Aug 21, 23
EF Hutton Buy Jul 17, 23
EF Hutton Buy Mar 30, 23
EF Hutton Buy Feb 28, 23
HC Wainwright & Co. Buy Feb 27, 23
HC Wainwright & Co. Buy Aug 19, 22
HC Wainwright & Co. Buy Mar 29, 22
EF Hutton Buy Dec 2, 21
Insider Trades Relationship Date Transactions Cost($) #Shares Value($) #Share Own SEC Form 4
Ghadar-Ghadr Arash Chief Operating Offi.. Chief Operating Officer Jan 05 Buy 0.14 100,000 14,000 100,000 01/09/24